Interpace Diagnostics Enters Agreement with One of the Largest, Integrated Health Systems in the US
April 18, 2018 08:30 ET | Interpace Diagnostics Group, Inc.
PARSIPPANY, N.J., April 18, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group (NASDAQ:IDXG) (“Interpace” or “the Company”), a fully integrated commercial and bioinformatics company that provides...
gmi logo.jpg
Carcinoembryonic Antigen Market to hit $2.7bn by 2023: Global Market Insights, Inc.
April 20, 2017 06:30 ET | Global Market Insights, Inc
Ocean View, Delaware, April 20, 2017 (GLOBE NEWSWIRE) -- The research report “Carcinoembryonic Antigen (CEA) Market Size By Application (Colorectal, Pancreatic, Ovarian, Breast, Thyroid Cancer),...
Fertility Drugs Increase Thyroid Cancer Risk
October 09, 2009 14:52 ET | Larry and Belinda Wurn
GAINESVILLE, FL--(Marketwire - October 9, 2009) - Women who take the most common fertility drugs, progesterone and clomiphene, are at a greater risk to develop thyroid cancer than those who don't,...
PenCol Compounding Pharmacy Has Solution for Armour(R) Thyroid Backorder
September 14, 2009 16:02 ET | PenCol Compounding Pharmacy
DENVER, CO--(Marketwire - September 14, 2009) - Forest Laboratories, Inc., the maker of the widely used hormone therapy drug, Armour® Thyroid, recently announced it has placed the medication on...